Trial Profile
A randomized, observer-blind, active-controlled, parallel-group, multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of compound S0597 by intranasal route in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs SUN 0597 (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Adverse reactions
- Sponsors Sun Pharmaceutical Industries
- 21 Mar 2012 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
- 12 Sep 2011 New trial record